Bloomberg Law
Free Newsletter Sign Up
Bloomberg Law
Advanced Search Go
Free Newsletter Sign Up

Latest Stories

Spectrum Pharmaceuticals Misled on Study Results, Investor Says

Spectrum Pharmaceuticals Inc. and three of its executives falsely told the public that poziotinib, a cancer drug in development, showed positive results in a clinical trial and that a confirmatory study was beginning, an investor says in a proposed class action.

Musk Says Deputy General Counsel ‘Exited’ From Twitter

Elon Musk says in a tweet that Twitter Deputy General Counsel James Baker was “exited” from the company on Tuesday in light of concerns about his “possible role in suppression of information important to the public dialogue.”

View More

The Billable Hour: Why Big Law Just Can't Quit It

The billable hour, for better or worse, dominates Big Law. Here's how that happened. Also, the main arguments for it, criticisms against it, and how some of the alternative fee arrangements stack up.

Up Next

Elon Musk, Twitter & Contract Law: Could He Have Bailed?

Clarence Thomas & Oral Arguments: Taciturn to Talkative

Union Busting: What Employers Can and Cannot Legally Do

Steven Davis and the Rise and Fall of Dewey & LeBoeuf

Pa. Homeowner Talks about an Unplugged Oil Well on Her Land

Preparedness Training at Massachusetts General Hospital

MicroStrategy's Unrelenting Bitcoin Bet

Is the Oxford Comma Controversial? Not for Lawyers

Fashion & the Law: Who Cares What Lawyers Wear?

Sen. Kelly Raises PFAS Issues in Environment & Public Works Hearing

Big Law Says Goodbye to Five-Day In-Office Work Weeks


LGBTQ Rights, Elections On Tap In Year-End Arguments

Big Tech Is Now a Big Player in US Energy Markets